Pyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury
health insurance claims data for more than 50 million people from 2022-2024 and determined that, after an initial jump in spending related to the start of injectable GLP-1 drugs like Ozempic (NVO) and Wegovy, cost growth for the treatment group trended at half the rate of a control group in the second year
Immunostaining revealed mixed cell populations with many undifferentiated hPSCs and mesoderm cells, and DE markers SOX17 and FOXA2 were expressed at lower levels compared to the Activin A-based control (CA)
A 4-week minimum hold at each dose cuts GI adverse event rates by roughly half
Its described antinociceptive effect in animals might decrease pain-induced impotence and increase sexual and reproductive function
Regen Doctors (Compounded Semaglutide: Injection, Melts and Drops), Report #7516, NAD/CARU Case Reports (November 2025)